Researchers Identified Two Molecular Subtypes of Autism
A new study reveals two distinct gene activity patterns in autism, which may help explain why individuals respond differently to treatment.
Updated on Sept. 25, 2026 in Autism
Live Poll
Do you believe research into specific autism molecular subtypes will improve treatment options for patients?
Scientists have identified two molecular subtypes of autism spectrum disorder, each characterized by opposing patterns of gene activity. This discovery, based on the analysis of over 1,000 brain samples, could eventually lead to more personalized treatment approaches for those affected.
Why it matters
Understanding the diverse genetic causes of autism through common molecular features is a critical step toward developing more precise medical interventions. These findings suggest that patients may respond to medications based on their specific biological profile rather than a singular diagnostic category.
Published in the journal Science, this study analyzed 1,008 human brain samples and 17 mouse models to categorize over 1,200 autism-associated genes into two distinct molecular subtypes. The research demonstrated that common psychiatric medications normalized gene abnormalities in only one subtype.
The details
The two subtypes are defined by inverse gene activity patterns: one shows decreased activity in synaptic genes and increased activity in RNA processing genes, while the other shows the opposite configuration. Researchers used 17 mouse models with specific mutations to map these molecular signatures, confirming the presence of these patterns in human RNA data. These profiles influence how individual biological systems react to drugs like fluoxetine and lithium, which were only effective in normalizing gene function within one of the identified groups.
Timeline
September 25, 2026: The research team published their findings in the journal Science.
Health Landscape
This research represents a major departure from traditional diagnostic methods that rely primarily on clinical observation. By identifying biological subgroups, the findings align with the growing medical trend of using precision medicine to categorize complex neurological conditions.
These findings are preliminary and do not currently change how autism is diagnosed or treated in clinical practice. If you are managing autism-related symptoms, discuss any questions about medication response with your physician rather than making adjustments based on experimental genetic research.
The takeaway
The discovery of distinct molecular subtypes suggests that the biological origins of autism are more varied than previously thought. Patients and families should continue to follow existing clinical guidelines while watching for future developments in precision neurology.
Further reading
For more information on the current understanding of neurological development and ongoing research, explore the Autism section of our site.
Live Poll
Do you believe research into specific autism molecular subtypes will improve treatment options for patients?
